BioMarin Pharmaceutical
BMRN
48,18 €
Share price
0.75%
Change (1 day)
-39.13%
Change (1 year)
Categories
Market capitalization of BioMarin Pharmaceutical (BMRN)
Market cap: €9.24 Billion
As of June 2025 BioMarin Pharmaceutical has a market cap of €9.24 Billion. This makes BioMarin Pharmaceutical the world's 1705th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of BioMarin Pharmaceutical from 1999 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | €9.24 B | -24.57% |
| 2024 | €12.25 B | -25.44% |
| 2023 | €16.42 B | -8.37% |
| 2022 | €17.93 B | 25.19% |
| 2021 | €14.32 B | 10.67% |
| 2020 | €12.94 B | -4.65% |
| 2019 | €13.57 B | 2.3% |
| 2018 | €13.26 B | 1.66% |
| 2017 | €13.05 B | -3.64% |
| 2016 | €13.54 B | -12.48% |
| 2015 | €15.47 B | 39.65% |
| 2014 | €11.08 B | 51.64% |
| 2013 | €7.30 B | 56.18% |
| 2012 | €4.67 B | 54.76% |
| 2011 | €3.02 B | 34.99% |
| 2010 | €2.23 B | 68.98% |
| 2009 | €1.32 B | 4.29% |
| 2008 | €1.27 B | -46.02% |
| 2007 | €2.35 B | 106.65% |
| 2006 | €1.13 B | 68.51% |
| 2005 | €0.67 B | 122.53% |
| 2004 | €0.30 B | -23.16% |
| 2003 | €0.39 B | 9.02% |
| 2002 | €0.36 B | -54.52% |
| 2001 | €0.79 B | 110.03% |
| 2000 | €0.37 B | -6.65% |
| 1999 | €0.40 B |
End of Day market cap according to different sources
On Jun 17th, 2025 the market cap of BioMarin Pharmaceutical was reported to be:
€9.17 Billion
€9.17 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Ultragenyx Pharmaceutical RARE | €3.00 B | -67.43% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | €0.10 B | -98.86% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | €0.19 B | -97.92% | 🇺🇸 USA |
 Sanofi SNY | €104.43 B | 1,030.14% | 🇫🇷 France |
 Amicus Therapeutics
FOLD | €1.55 B | -83.19% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | €2.45 B | -73.48% | 🇺🇸 USA |